Skip to Main Content
Try STAT+ TODAY
Trending:
Health
Biotech
STAT+
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

With $11 billion Acceleron deal, new Merck CEO hopes to convince investors there is a lot more to the biopharma giant

  • Matthew Herper

By Matthew Herper Sept. 30, 2021

Reprints
Rob Davis
Merck CEO Rob Davis Merck

Merck will continue to search out more acquisitions after its $11 billion purchase of biotech firm Acceleron Pharma, the company’s CEO told STAT in an interview Thursday.

But the CEO, Rob Davis, said he also believes that investors have not yet come to realize the value of the experimental drugs Merck is developing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Matthew Herper

Matthew Herper

Senior Writer, Medicine, Editorial Director of Events

Matthew Herper covers medical innovation — both its promise and its perils.

Tags

Create a display name to comment

This name will appear with your comment

‘Everybody has blood on their hands’: A decade-long battle…
‘Everybody has blood on their hands’: A decade-long battle over Medicare Advantage audits is coming to…
Long after the fire of a Covid-19 infection, mental…
Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder
People ‘shed’ high levels of coronavirus, study finds, but…
People ‘shed’ high levels of coronavirus, study finds, but most are likely not infectious after recovery…
Pharmalittle: Amgen pricing for Humira biosimilar may not help…
Pharmalittle: Amgen pricing for Humira biosimilar may not help patients; pharma wins court battle over drug…
Alphabet’s laid-off health tech employees on where their work…
Alphabet’s laid-off health tech employees on where their work heads next
FDA may not always require post-approval trials to be…
FDA may not always require post-approval trials to be enrolled before accelerated approvals

Recommended Stories